News
Meet Vaiomer at the AFSSI Connexions 2023 – Montpellier
> Looking forward to fruitful discussions with the participants, at «la 10e édition des AFSSI Connexions» on July 04 and 05.
Vaiomer is taking part to « la deuxième édition de LA JOURNÉE DU MICROBIOTE»
> Vaiomer will be participating to « la deuxième édition de LA JOURNÉE DU MICROBIOTE», on June 27 in Paris, FRANCE.
> Do not miss our talk on Exploring the microbiome beyond the gut: Example of skin microbiota alteration by tick bites. More
Mouse models with human microbiome
Physiogenex, a leading preclinical contract research organization specialized in metabolic diseases and complications, and Vaiomer, a pioneer company in the field of microbiota, launch the TRANSBIOTIC project: a new research project to transplant mice with human fecal microbiome isolated from patients suffering various metabolic and inflammatory diseases.
Vaiomer is honored to sponsor the « Journées Polepharma De Microbiomique, 3ème édition »
> Vaiomer will be taking part in the 3rd edition of the « Journées Polepharma De Microbiomique » on December 14th & 15th in Rouen, FRANCE.
> Join us on our booth #11 to learn more about microbiomes beyond the gut.
> Do not miss our talk on exploring the microbiomes from gut and beyond, Thursday 15th at 14:35.
Vaiomer is participating in the next Neurex meeting on advanced concepts in neuroimmunology
> Vaiomer is taking part in the meeting “Advanced Concepts In Neuroimmunology: From Environmental Stressors To Neurological Disorders” on November 24 in Strasbourg, FRANCE.
> Do not miss our talk on “Tissue microbiota analysis for pathogen identification and skin microbiome alteration assessment after tick bite” at 14:45.
Vaiomer is honored to sponsor the Microbiome R&D and Business Collaboration Forum: Europe 2022
> Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum on May 24 & 25, in The Hague, THE NETHERLANDS
> Come visit our booth and do not miss our talk “Bacterial translocation: a new perspective on the microbiota-gut-brain axis?”
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.
Vaiomer is taking part to the next Eurobiomed cluster thematic meeting on Oncology
> Vaiomer will be participating to Oncology: Horizon 2030 Technologies and models to address tumor heterogeneity for better personalized medicine, on May 12 in Toulouse, FRANCE.
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.
Vaiomer is honored to sponsor Pharmabiotics 2022 Conference & Partnering
> Vaiomer will be attending Pharmabiotics 2022 on April 20 & 21 in Lyon, FRANCE.
> Join us on our booth to learn more about microbiomes beyond the gut
Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum: Europe
> Vaiomer is honored to sponsor the 9th Microbiome R&D and Business Collaboration Forum: Europe in Rotterdam on October 26 and 27.
> Visit our booth (#3) and come chat with our representatives to learn more about microbiomes beyond the gut.
Vaiomer is honored to sponsor the 8th IHMC Congress
> Vaiomer is happy to announce that we will be attending the 8th IHMC Virtual Congress 2021 on June 27, 28 & 29.
> Visit our virtual stand and come chat with us about microbiomes beyond the gut!